The U.S. District Court for the District of New Jersey has granted AstraZeneca Pharmaceuticals‘ motion for a temporary restraining order (TRO) halting sales of Teva’s generic Pulmicort Respules (budesonide inhaled solution). In conjunction with the order against Teva, AZ will also stop all sales of its authorized generic budesonide inhalation suspension product and take the necessary steps to comply with the Court’s decision. Par Pharmaceutical is the licensed distributor for A...